M48L (p.Met48Leu) variant of CDKN2A (Tumor suppressor ARF)

M48L (p.Met48Leu) in CDKN2A (Tumor suppressor ARF) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Hereditary cancer-predisposing syndrome. The available variant effect predictions contribute to a CATVariant prioritization score of 0.69 / 1. The record also includes population frequency data, published literature, and structural context.

M48L (p.Met48Leu) variant details